COVANCE
LIVE

Serial Number

86567126

Owner

COVANCE INC.

Attorney

William M. Bryner

Filing Date

Mar 17, 2015

Add to watchlist:

No watchlists yet
View on USPTO

COVANCE Trademark

Serial Number: 86567126 • Registration: 4897520

COVANCE is a trademark filed by COVANCE INC. on March 17, 2015. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 16 (Paper Goods), Class 31 (Natural Agricultural Products), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

COVANCE INC. (60 trademarks)

210 Carnegie Center
Princeton, NJ 085406233

Entity Type: 03

LABCORP DRUG DEVELOPMENT INC. (26 trademarks)

210 CARNEGIE CENTER
PRINCETON, NJ 085406233

Entity Type: 03

Trademark Details

Filing Date

March 17, 2015

Registration Date

February 9, 2016

Published for Opposition

November 24, 2015

Goods & Services

Downloadable electronic publications, namely, books, pamphlets, articles, technical manuals, instructional and teaching materials, and reports in the fields of research and development of pharmaceutical, medical devices, biotechnology, and biochemicals

Printed matter, namely, books, pamphlets, articles, technical manuals, instructional and teaching materials, and reports in the fields of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals

Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs

Business consultancy services; business management consultancy and advisory services; consultancy and advisory services in the field of business strategy; marketing services; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting and analysis; market research; business consulting services in the field of commercialization of pharmaceuticals, medical devices, biotechnology, and biochemicals; business management services, namely, forecasting drug supplies for clinical trials; business management services, namely, recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; project management services for others for business purposes in the field of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; database management; business information services; business data analysis; business advice and commercial information

Regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices; regulatory compliance consulting in the field of food safety and nutritional labeling; providing information and advisory services about regulatory compliance in the fields of pharmaceuticals, medical devices, food safety, and nutritional labeling

Medical services in the fields of pathology, pharmacology, and immunology; medical and psychological counseling; providing medical information and advice in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices

[ Live animals; live laboratory animals ]

Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; rental of laboratory apparatus and instruments; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; testing of laboratory animals for scientific research purposes; computer hardware and software design; development, updating and maintenance of software and databases; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical and medical device and development studies; providing online computer databases in the fields of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; food safety testing and consultation related thereto; scientific research and analysis in the fields of food safety, food packaging, and nutritional chemistry; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals and clinical trials; providing online non-downloadable software for tracking, monitoring, analyzing, generating and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 9, 2025 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 7, 2022 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 4, 2021 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 4, 2021 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 4, 2021 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 30, 2021 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 9, 2021 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 20, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 20, 2018 REAP
REGISTERED-PRINCIPAL REGISTER
Feb 9, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 24, 2015 NPUB
PUBLISHED FOR OPPOSITION
Nov 24, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 4, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 16, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 7, 2015 CNSA
ASSIGNED TO EXAMINER
Oct 7, 2015 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jun 23, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jun 23, 2015 CNRT
ASSIGNED TO EXAMINER
Jun 19, 2015 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Apr 6, 2015 AMPX
ASSIGNED TO LIE
Apr 6, 2015 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 30, 2015 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2015 NWOS
NEW APPLICATION ENTERED
Mar 20, 2015 NWAP